These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 236102)

  • 21. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
    Suzuki Y
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency.
    De Deyn PP; Marescau B; Cuykens JJ; Van Gorp L; Lowenthal A; De Potter WP
    Clin Chim Acta; 1987 Jul; 167(1):81-8. PubMed ID: 3665089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds.
    Eloot S; Torremans A; De Smet R; Marescau B; De Wachter D; De Deyn PP; Lameire N; Verdonck P; Vanholder R
    Kidney Int; 2005 Apr; 67(4):1566-75. PubMed ID: 15780113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
    Levillain O; Marescau B; de Deyn PP
    Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of guanidino compounds by anion-exchange chromatography and amperometric detection.
    Ding WD; Veening H; Van Effen RM
    J Chromatogr; 1990 Apr; 526(2):355-66. PubMed ID: 2361978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-performance liquid chromatographic analysis of guanidino compounds using ninhydrin reagent. II. Guanidino compounds in blood of patients on haemodialysis therapy.
    Hiraga Y; Kinoshita T
    J Chromatogr; 1985 Aug; 342(2):269-75. PubMed ID: 4055949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of guanidino-propionic acid on lymphocyte proliferation.
    Shainkin-Kestenbaum R; Winikoff Y; Dvilansky A; Chaimovitz C; Nathan I
    Nephron; 1986; 44(4):295-8. PubMed ID: 3796772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
    De Deyn PP; Macdonald RL
    Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
    D'Hooge R; Pei YQ; Marescau B; De Deyn PP
    J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats.
    Levillain O; Marescau B; Possemiers I; De Deyn PP
    Metabolism; 2008 Jun; 57(6):802-10. PubMed ID: 18502263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automatic system for the assay of guanidino compounds to assess uremic status.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T; Watanabe M
    Biol Pharm Bull; 2000 Sep; 23(9):1015-20. PubMed ID: 10993196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid chromatography of guanidino compounds using a porous graphite carbon column and application to their analysis in serum.
    Inamoto Y; Inamoto S; Hanai T; Tokuda M; Hatase O; Yoshii K; Sugiyama N; Kinoshita T
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):111-20. PubMed ID: 9613940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 34. High-performance liquid chromatographic analyser for guanidino compounds using benzoin as a fluorogenic reagent.
    Hung YL; Kai M; Nohta H; Ohkura Y
    J Chromatogr; 1984 Feb; 305(2):281-94. PubMed ID: 6707159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure.
    Sawynok J; Dawborn JK
    Clin Exp Pharmacol Physiol; 1975; 2(1):1-15. PubMed ID: 1126056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gas chromatographic and gas chromatographic-mass spectrometric analysis of organic acids in plasma of patients with chronic renal failure.
    Liebich HM; Pickert A; Tetschner B
    J Chromatogr; 1984 Apr; 289():259-66. PubMed ID: 6547446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic relationship between urea and guanidino compounds as studied by automated fluorimetry of guanidino compounds in urine.
    Natelson S
    Clin Chem; 1984 Feb; 30(2):252-8. PubMed ID: 6692530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anisoin: a useful pre-chromatographic derivatization fluorogenic reagent for LC analysis of guanidino compounds.
    Gatti R; Gioia MG
    J Pharm Biomed Anal; 2006 Sep; 42(1):11-6. PubMed ID: 16460903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of guanidino compounds in serum and brain of mouse, rat, rabbit, and man.
    Marescau B; De Deyn P; Wiechert P; Van Gorp L; Lowenthal A
    J Neurochem; 1986 Mar; 46(3):717-20. PubMed ID: 3950603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperprolactinemia and guanidinosuccinic acid in chronic renal failure].
    Fujimura A; Kawato M; Nakabayashi H; Tofuku Y; Noto M; Akiyama T; Kido C; Kuroda M; Takeda R
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):199-204. PubMed ID: 6620688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.